ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis

Pang, Xiangyi; Xu, Benjie; Lian, Jie; Wang, Ren; Wang, Xin; Shao, Jiayue; Tang, Shuli; Lu, Haibo*哈尔滨医科大学
Frontiers in Oncology2022-9-16DOI: 10.3389/fonc.2022.914076
4被引22阅读
引用收藏
分享

摘要

The survival rate for colon cancer after radical surgery has been the focus of extensive debate. To assess the postoperative survival and prognostic factors for overall survival (OS), we collected clinicopathological information for 2,655 patients. The survival time and potential risk factors for OS were analyzed by using Kaplan-Meier curves, Cox proportional hazards models, best subset regression (BSR), and least absolute shrinkage and selection operator (LASSO). The 5-year survival rates of stage I-IV colon cancer were 96.6%, 88.7%, 69.9%, and 34.3%, respectively. Adjuvant chemotherapy improved the survival rate (90.4% vs. 82.4%, with versus without adjuvant chemotherapy, respectively) in stage II patients with high-risk factors. Elevated preoperative carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19 -9) were significantly associated with worse OS compared with patients without these elevations. Less than 12 versus more than 12 harvested lymph nodes (LNs) affected prognosis (84.6% vs. 89.7%, respectively). Regarding the lymph node ratio (LNR), the 5-year OS rate was 89.2%, 71.5%, 55.8%, and 34.5% in patients with LNR values of 0, 0.3, 0.3-0.7, and >0.7, respectively. We constructed a nomogram comprising the independent factors associated with survival to better predict prognosis. On the basis of these findings, we propose that stage II colon cancer patients without high-risk factors and with both elevated preoperative CEA and CA199 should receive adjuvant therapy. Furthermore, the LNR could complement TNM staging in patients with <12 harvested LNs. Our nomogram might be useful as a new prognosis prediction system for colon cancer patients.

学科与关键词

关键词
colon cancerradical surgerysurvival ratenomogramprognostic factors
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-09-16
卷期
第 12 卷
页码
914076
DOI
10.3389/fonc.2022.914076
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [U20A20376, 61972116]; Beijing Award Foundation [YXJL-2020-0818-0478]; Wu Jieping Medical Foundation [320.6750.2020-19-20]; Heilongjiang Province Postdoctoral Science Foundation [LBHZ21189]; Harbin Medical University Innovative Science Research Funded Project [31041220028]; China Postdoctoral Science Foundation [2022MD713747]

作者

  • P

    Pang, Xiangyi (第一作者)

    harbin med univ

  • X

    Xu, Benjie

    harbin med univ

查看全部 8 位作者收起作者
  • L

    Lian, Jie

    harbin med univ

  • W

    Wang, Ren

    harbin med univ

  • W

    Wang, Xin

    harbin med univ

  • S

    Shao, Jiayue

    harbin med univ

  • T

    Tang, Shuli

    harbin med univ

  • L

    Lu, Haibo (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417